289 related articles for article (PubMed ID: 23829373)
1. Mechanisms of drug resistance in cancer chemotherapy: coordinated role and regulation of efflux transporters and metabolizing enzymes.
Vadlapatla RK; Vadlapudi AD; Pal D; Mitra AK
Curr Pharm Des; 2013; 19(40):7126-40. PubMed ID: 23829373
[TBL] [Abstract][Full Text] [Related]
2. Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters.
Chen Y; Tang Y; Guo C; Wang J; Boral D; Nie D
Biochem Pharmacol; 2012 Apr; 83(8):1112-26. PubMed ID: 22326308
[TBL] [Abstract][Full Text] [Related]
3. Pregnane X receptor and its potential role in drug resistance in cancer treatment.
Chen Y; Nie D
Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):19-27. PubMed ID: 19149685
[TBL] [Abstract][Full Text] [Related]
4. Overcoming drug resistance by regulating nuclear receptors.
Chen T
Adv Drug Deliv Rev; 2010 Oct; 62(13):1257-64. PubMed ID: 20691230
[TBL] [Abstract][Full Text] [Related]
5. Influence of multidrug resistance and drug transport proteins on chemotherapy drug metabolism.
Joyce H; McCann A; Clynes M; Larkin A
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):795-809. PubMed ID: 25836015
[TBL] [Abstract][Full Text] [Related]
6. [Modulation of nuclear receptors on drug-metabolizing enzymes and transporters].
Liu ZH; Li Y
Yao Xue Xue Bao; 2012 Dec; 47(12):1575-81. PubMed ID: 23460960
[TBL] [Abstract][Full Text] [Related]
7. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
8. [Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance].
Wei N; Sun H; Liu GT
Yao Xue Xue Bao; 2010 Oct; 45(10):1205-11. PubMed ID: 21348297
[TBL] [Abstract][Full Text] [Related]
9. Implication of metabolomics and transporter modulation based strategies to minimize multidrug resistance and enhance site-specific bioavailability: a needful consideration toward modern anticancer drug discovery.
Rachmale M; Rajput N; Jadav T; Sahu AK; Tekade RK; Sengupta P
Drug Metab Rev; 2022 May; 54(2):101-119. PubMed ID: 35254954
[TBL] [Abstract][Full Text] [Related]
10. Xenobiotic Nuclear Receptors Pregnane X Receptor and Constitutive Androstane Receptor Regulate Antiretroviral Drug Efflux Transporters at the Blood-Testis Barrier.
Whyte-Allman SK; Hoque MT; Jenabian MA; Routy JP; Bendayan R
J Pharmacol Exp Ther; 2017 Dec; 363(3):324-335. PubMed ID: 28970358
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms and strategies to overcome multiple drug resistance in cancer.
Ozben T
FEBS Lett; 2006 May; 580(12):2903-9. PubMed ID: 16497299
[TBL] [Abstract][Full Text] [Related]
12. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski E; Bontemps-Gracz MM; Piwkowska A
Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
[TBL] [Abstract][Full Text] [Related]
13. Coordinated nuclear receptor regulation of the efflux transporter, Mrp2, and the phase-II metabolizing enzyme, GSTpi, at the blood-brain barrier.
Bauer B; Hartz AM; Lucking JR; Yang X; Pollack GM; Miller DS
J Cereb Blood Flow Metab; 2008 Jun; 28(6):1222-34. PubMed ID: 18349876
[TBL] [Abstract][Full Text] [Related]
14. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and therapeutic potential of inhibiting drug efflux transporters.
Klukovits A; Krajcsi P
Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):907-20. PubMed ID: 25802976
[TBL] [Abstract][Full Text] [Related]
16. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
McIntosh K; Balch C; Tiwari AK
Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
[TBL] [Abstract][Full Text] [Related]
17. Pregnane X receptor and human malignancy.
Koutsounas I; Patsouris E; Theocharis S
Histol Histopathol; 2013 Apr; 28(4):405-20. PubMed ID: 23413096
[TBL] [Abstract][Full Text] [Related]
18. Drug Transporters and Multiple Drug Resistance in Pediatric Solid Tumors.
Fruci D; Cho WC; Nobili V; Locatelli F; Alisi A
Curr Drug Metab; 2016; 17(4):308-16. PubMed ID: 26694726
[TBL] [Abstract][Full Text] [Related]
19. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR.
Mohammad IS; He W; Yin L
Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043
[TBL] [Abstract][Full Text] [Related]
20. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
